Table 3. Multivariate analysis of CEUS features with BRAF mutation in PTC.
| CEUS features | BRAF (+) | BRAF (−) | OR (95% CI) | P |
|---|---|---|---|---|
| Size of the enhanced lesions (larger) | 391 | 180 | 1.050 (0.828–1.332) | 0.687 |
| Degree of enhancement (no significant enhancement) | 813 | 377 | 0.790 (0.639–0.977) | 0.030 |
| Method of enhancement (centripetal) | 336 | 128 | 1.465 (1.129–1.903) | 0.004 |
| Homogeneity of enhancement (inhomogeneous) | 364 | 164 | 0.806 (0.617–1.053) | 0.113 |
| Completeness of enhancement (complete) | 863 | 400 | 2.010 (0.619–6.525) | 0.245 |
| Wash out period (with wash out period) | 129 | 58 | 0.814 (0.576–1.149) | 0.242 |
| Boundary of the enhanced lesions (blurred) | 750 | 350 | 1.030 (0.702–1.510) | 0.880 |
| Shape of the enhanced lesions (irregular) | 851 | 394 | 1.073 (0.398–2.897) | 0.889 |
CEUS, contrast-enhanced ultrasound; PTC, papillary thyroid carcinoma.